Abortion

The Trump Administration has taken numerous steps to significantly alter the Title X program, the federal grant program that supports family planning services to low-income women. This brief provides an overview of the Title X program, discusses the new 2018 funding announcement and related litigation, and reviews the Trump Administration’s proposed regulations and the implications of these changes.

This map presents the share of Title X clinics that are Planned Parenthood clinics and/or provide abortions (as of 05/2019) and would no longer qualify for funding unless they separate from Planned Parenthood Federation of America or physically separate their abortion services from their family planning care.

KFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health. The dashboard provides instant access the most up-to-date state level indicators of women’s health in the U.S. Many of the indicators also provide national and…

In a new brief, KFF examines how the Comstock Act, an 1873 anti-vice law banning the mailing of obscene matter and articles, could be used by an anti-abortion presidential administration to sharply restrict the availability of abortion nationwide.  The Biden Administration’s Department of Justice has said the Comstock Act should…

A new KFF survey of office-based OBGYNs finds widespread effects on their practices and patients since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization one year ago.  In states with abortion bans, half say that they have patients who have been unable to obtain an abortion, about…

Nearly a year after the Supreme Court overturned Roe v. Wade, this poll examines the public’s views of abortion and the Supreme Court, and knowledge about mifepristone, a medication abortion drug that is the subject of another court case, the ACA’s preventive services provision and HIV in the US.

More than six months since the Supreme Court issued their Dobbs decision which overturned Roe v. Wade, there is widespread public confusion about the medication abortion pill and whether it is legal at the state level, according to the latest KFF Health Tracking Poll. The poll also finds many are…

Following the FDA approval of retail pharmacies carrying and distributing medication abortion, this poll finds that the public’s awareness and knowledge of emergency contraception and medication abortion is still lacking, especially among respondents living in states with full abortion bans.

KFF has created two new trackers to follow swift-moving reproductive rights litigation in the state and federal courts. The tools, which are currently tracking the status of 21 state cases in 15 states and eight federal cases, will be updated regularly as the litigation proceeds. Major cases pending in federal…

This report highlights key findings from the 2020 KFF National Physician Survey on Reproductive Health that asked a nationally representative sample of OBGYNs practicing in the United States about a wide range of issues, including their provision of contraception, abortion, and STI care.